Atea Pharmaceuticals Inc

10-Year Study

AVIR.US · Healthcare · US · Common Stock

Executive Summary: Atea Pharmaceuticals Inc has compounded at -1.3% annually over the last 10 years, with a maximum drawdown of 96.2% and an annualized volatility of 162.4%.

1Y CAGR
+103.6%
3Y CAGR
+13.0%
5Y CAGR
-8.5%
10Y CAGR
-1.3%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
96.2%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.53
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
1.62
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
172.4%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2020 · +573.9%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2021 · -78.6%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
57%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
202618.810.415.05.9————————59.7%
2025-8.7-1.0-1.3-1.30.721.21.1-7.7-13.712.1-4.615.26.6%
202436.43.6-6.3-8.4-0.8-9.815.40.8-13.0-3.35.6-2.09.8%
2023-3.7-23.5-5.4-2.422.0-6.3-8.3-2.0-10.78.3-8.02.0-36.6%
2022-20.1-11.213.9-18.734.2-9.915.5-8.5-24.15.4-21.82.6-46.2%
202174.73.2-18.1-60.0-64.4144.116.618.718.0-66.8-30.510.5-78.6%
202014.5-1.7-38.418.65.50.913.32.4-2.5394.19.825.4573.9%
2019————-5.3-0.3-3.45.32.5-5.7-0.37.3-0.8%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 162.4%. The dominant macroeconomic risk driver is SHV.US, accounting for 77.6% of variance. Idiosyncratic stock-specific factors contribute 14.4%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2019-04-0110000
2019-05-019472.000122070312
2019-06-019440.00015258789
2019-07-019119.999694824219
2019-08-019600
2019-09-019840.00015258789
2019-10-019280.000305175781
2019-11-019248.00033569336
2019-12-019919.999694824219
2020-01-0111359.99984741211
2020-02-0111168.000030517578
2020-03-016880.00030517578
2020-04-018159.999847412109
2020-05-018608.000183105469
2020-06-018687.999725341797
2020-07-019840.00015258789
2020-08-0110080.00030517578
2020-09-019823.999786376953
2020-10-0148544
2020-11-0153312
2020-12-0166848
2021-01-01116800
2021-02-01120576.00000000001
2021-03-0198800.00000000001
2021-04-0139536
2021-05-0114080.000305175781
2021-06-0134368
2021-07-0140064
2021-08-0147551.99999999999
2021-09-0156096
2021-10-0118624
2021-11-0112944
2021-12-0114303.999999999998
2022-01-0111423.999999999998
2022-02-0110144
2022-03-0111552
2022-04-019392
2022-05-0112608
2022-06-0111359.999999999998
2022-07-0113119.999999999998
2022-08-0112000
2022-09-019104.000000000002
2022-10-019600
2022-11-017504.000000000001
2022-12-017695.999999999999
2023-01-017408
2023-02-015664
2023-03-015360
2023-04-015232
2023-05-016384.000000000001
2023-06-015984
2023-07-015488.000000000001
2023-08-015376
2023-09-014800
2023-10-015200
2023-11-014784.000000000001
2023-12-014880
2024-01-016656
2024-02-016896
2024-03-016464
2024-04-015920.000000000001
2024-05-015871.999999999999
2024-06-015296
2024-07-016112
2024-08-016160
2024-09-015360
2024-10-015184.000000000001
2024-11-015472
2024-12-015360
2025-01-014896
2025-02-014847.999999999999
2025-03-014784.000000000001
2025-04-014720
2025-05-014752
2025-06-015760.000000000001
2025-07-015824
2025-08-015376
2025-09-014640
2025-10-015200
2025-11-014960
2025-12-015711.999999999999
2026-01-016784
2026-02-017487.999999999999
2026-03-018608
2026-04-019120
Annual Return Matrix
YearAnnual Return
20205.738709884726921
2021-0.7860220201053135
2022-0.46196868008948544
2023-0.3659043659043659
20240.09836065573770503
20250.06567164179104479
20260.596638655462185
Total Factor Risk
1.6243778964011268
VTI.US Exposure
-0.00006679756416544497
VEA.US Exposure
0.009604390236656615
VWO.US Exposure
-0.00018848475942988242
QQQ.US Exposure
0.0007421217694203951
VTV.US Exposure
0.0018773601157458391
IJR.US Exposure
0.0013527169825202992
QUAL.US Exposure
0.004018147752972985
SHV.US Exposure
0.7763071157403058
TLT.US Exposure
0.01219828216729255
LQD.US Exposure
0.017984448364118787
HYG.US Exposure
0.006947536370696258
GLD.US Exposure
0.003777833493445328
USO.US Exposure
0.0028175538033884786
VNQ.US Exposure
-0.00021151045661551958
BTC-USD.CC Exposure
0.000620988247773052
CPER.US Exposure
0.0005662947411925791
VIX.INDX Exposure
0.007240290225285145
UUP.US Exposure
0.010289925959570186
TIP.US Exposure
0.0002852606140293355
Idiosyncratic Exposure
0.1438365261957977
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
162.4%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$458.9M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+8.5%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+47.0%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
26.0% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
0.16
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Atea Pharmaceuticals Inc a high-risk investment?

Atea Pharmaceuticals Inc (AVIR.US) has an annualized volatility of 162.4% and experienced a maximum drawdown of 96.2% over the last 10 years. Its primary macro risk driver is SHV.US.

What is the 10-year return of AVIR.US?

Over the past 10 years, AVIR.US has generated a Compound Annual Growth Rate (CAGR) of -1.3%. It has had a positive return in 57% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Atea Pharmaceuticals Inc

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest